Renal transplantation in AA amyloidosis associated with Whipple’s disease

References

• Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull John Hopkins Hosp 1907; 18:382–391.
   Google Scholar
• Raoult D, Birg ML, La Scola B, Fournier PE, Enea M, Lepidi H, Roux V, et al. Cultivation of the bacillus of Whipple’s disease. N Engl J Med 2000;342:620–625.
   PubMed Web of Science ®Google Scholar
• Fenollar F, Puéchal X, Raoult D. Whipple’s disease. N Engl J Med 2007;356:55–66.
   PubMed Web of Science ®Google Scholar
• Famularo G, Minisola G, De Simone C. A patient with cerebral Whipple’s disease and a stroke-like syndrome. Scand J Gastroenterol 2005;40:607–609.
   PubMed Web of Science ®Google Scholar
• Dearment MC, Woodward TA, Menke DM, Brazis PW, Bancroft LW, Persellin ST. Whipple’s disease with destructive arthritis, abdominal lymphadenopathy, and central nervous system involvement. J Rheumatol 2003;30:1347–1350.
   PubMed Web of Science ®Google Scholar
• James TN, Bulkley BH. Abnormalities of the coronary arteries in Whipple’s disease. Am Heart J 1983;105:481–491.
   PubMedGoogle Scholar
• Biernat S, Kozlowski W. [Case of Whipple’s disease complicated by amyloidosis]. Pol Tyg Lek 1975;30:113–114.
   PubMedGoogle Scholar
• Cruz I, Oliveira AP, Lopes JM, Ricardo JL, de Freitas J. Whipple’s disease and renal amyloidosis. Am J Gastroenterol 1993;88:1954–1956.
   PubMed Web of Science ®Google Scholar
• Leidig P, Stolte M, Krakamp B, Störkel S. [Whipple’s disease – a rare cause of secondary amyloidosis]. Z Gastroenterol 1994;32:109–112.
   PubMedGoogle Scholar
• Kramer LC, Manschot TAJM, Barendregt JNM, Smit JM. Whipple’s disease: often a late diagnosis and a rare cause of nephropathy. Nephrol Dial Transplant Plus 2009; 2: 55–58.
   Google Scholar
• Niemczyk S, Filipowicz E, Wozniacki L, Grochowski J, Zaleski L, Grzejszczak A, Ptasinska AP, et al. Renal amyloidosis in Whipple disease: a case report. Cases J 2009;2:8444.
   PubMedGoogle Scholar
• Stoll T, Keusch G, Jost R, Burger H, Oelz O. IgA nephropathy and hypercalcemia in Whipple’s disease. Nephron 1993;63:222–225.
   PubMedGoogle Scholar
• Evrenkaya R, Basak M, Cosansel S, Cankir Z, Güney Y, Kurtoglu S, Yildirim S, et al. A case of Whipple’s disease associated with acute Ebstein Barr virus hepatitis and Berger’s disease. Nephrol Dial Transplant 1999;14:241–242.
   PubMedGoogle Scholar
• Schlumpf A, Marbet UA, Stöcklin E, Wegmann W, Lämmle B, Mujagic M, Jösch W, et al. Chronic interstitial nephritis in Whipple’s disease. Klin Wochenschr 1983;61:25–33.
   PubMedGoogle Scholar
• Marie I, Lecomte F, Levesque H. Granulomatous nephritis as the first manifestation of Whipple disease. Ann Intern Med 2000;132:94–95.
   PubMedGoogle Scholar
• Sander S. Whipple’s disease associated with amyloidosis. Acta Pathol Microbiol Scand 1964;61:530–536.
   PubMedGoogle Scholar
• Fleming JL, Wiesner RH, Shorter RG. Whipple’s disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc 1988;63:539–551.
   PubMed Web of Science ®Google Scholar
• Kleine G. Weight loss, renal insufficiency, aortal stenosis and arthralgies. Der Internist 2005; 46: 575–579.
   PubMedGoogle Scholar
• Pasternack A, Ahonen J, Kuhlbäck B. Renal transplantation in 45 patients with amyloidosis. Transplantation 1986;42:598–601.
   PubMedGoogle Scholar
• Haq A, Hussain S, Meskat B, Mohan P, Conlon P, Hickey DP. Complications of renal transplantation in patients with amyloidosis. Transplant Proc 2007;39:120–124.
   PubMedGoogle Scholar
• Sherif AM, Refaie AF, Sobh MA, Mohamed NA, Sheashaa HA, Ghoneim MA. Long-term outcome of live donor kidney transplantation for renal amyloidosis. Am J Kidney Dis 2003;42:370–375.
   PubMedGoogle Scholar
• Sobh M, Refaie A, Moustafa F, Shokeir A, Hassan N, Sally S, Ghoneim M. Study of live donor kidney transplantation outcome in recipients with renal amyloidosis. Nephrol Dial Transplant 1994;9:704–708.
   PubMedGoogle Scholar
• Razonable RR, Pulido JS, Deziel PJ, Dev S, Salomão DR, Walker RC. Chorioretinitis and vitreitis due to Tropheryma whipplei after transplantation: case report and review. Transpl Infect Dis 2008;10:413–418.
   PubMedGoogle Scholar
• Mahnel R, Kalt A, Ring S, Stallmach A, Strober W, Marth T. Immunosuppressive therapy in Whipple’s disease patients is associated with the appearance of gastrointestinal manifestations. Am J Gastroenterol 2005;100:1167–1173.
   PubMed Web of Science ®Google Scholar
• Marth T, Roux M, von Herbay A, Meuer SC, Feurle GE. Persistent reduction of complement receptor 3 alpha-chain expressing mononuclear blood cells and transient inhibitory serum factors in Whipple’s disease. Clin Immunol Immunopathol 1994;72:217–226.
   PubMedGoogle Scholar
• Bjerknes R, Odegaard S, Bjerkvig R, Børkje B, Laerum OD. Whipple’s disease. Demonstration of a persisting monocyte and macrophage dysfunction. Scand J Gastroenterol 1988;23:611–619.
   PubMed Web of Science ®Google Scholar
• Marth T, Kleen N, Stallmach A, Ring S, Aziz S, Schmidt C, Strober W, et al. Dysregulated peripheral and mucosal Th1/Th2 response in Whipple’s disease. Gastroenterology 2002;123:1468–1477.
   PubMed Web of Science ®Google Scholar
• Migita K, Yamasaki S, Shibatomi K, Ida H, Kita M, Kawakami A, Eguchi K. Impaired degradation of serum amyloid A (SAA) protein by cytokine-stimulated monocytes. Clin Exp Immunol 2001;123:408–411.
   PubMed Web of Science ®Google Scholar